ANACOR PHARMACEUTICALS, INC.

Profile

Company Names

ANACOR PHARMACEUTICALS, INC.
ANACOR PHARMACEUTICALS INC

Addresses

1020 E. MEADOW CIRCLE, PALO ALTO, CA 94303

Phone Numbers

650-543-7500

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$15,000,000.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2013-06-07 
$0.00 
$2,700,000.00 
$2,700,000.00 
 
3
2013-04-05 
$5,000,000.00 
$5,000,000.00 
$0.00 
Equity 
2
2011-03-18 
$0.00 
$1,650,000.00 
$1,650,000.00 
 
1
2010-11-30 
$10,000,000.00 
$10,000,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
PAUL 
 
BERNS 
DIRECTOR
ANACOR PHARMACEUTICALS, INC.   |  CELLECTAR BIOSCIENCES, INC.   |  UNITY BIOTECHNOLOGY, INC.   |  ARCH VENTURE FUND XII, L.P.   |  ELEPHAS BIOSCIENCES CORP   |  ARETEIA THERAPEUTICS, INC.   |  NEUMORA THERAPEUTICS, INC.   |  MIRADOR THERAPEUTICS, INC.   |  OLLIN BIOSCIENCES, INC.
SANJAY 
 
CHANDA 
EXECUTIVE OFFICER
ANACOR PHARMACEUTICALS, INC.   |  AN2 THERAPEUTICS, INC.
IRWIN 
 
HEYMAN 
EXECUTIVE OFFICER
ANACOR PHARMACEUTICALS INC
ZHI 
 
HONG 
DIRECTOR
ANACOR PHARMACEUTICALS INC   |  IMMUNESENSOR THERAPEUTICS, INC.
ANDERS 
 
HOVE 
DIRECTOR
QUATRX PHARMACEUTICALS CO   |  ALIMERA SCIENCES INC   |  VIRDANTE PHARMACEUTICALS, INC.   |  ANACOR PHARMACEUTICALS INC   |  STILL RIVER SYSTEMS INC   |  MEVION MEDICAL SYSTEMS, INC.   |  ANACOR PHARMACEUTICALS, INC.
PAUL 
 
KLINGENSTEIN 
DIRECTOR
ENTEROMEDICS INC   |  AVIIR INC   |  VERTIFLEX INC   |  POSIT SCIENCE CORP   |  CONATUS PHARMACEUTICALS INC   |  ANACOR PHARMACEUTICALS INC   |  MC10, INC.   |  ANACOR PHARMACEUTICALS, INC.   |  CLOVIS ONCOLOGY, INC.   |  IDUN PHARMACEUTICALS INC
MARK 
 
LESCHLY 
DIRECTOR
SLACKER INC   |  BROADLOGIC NETWORK TECHNOLOGIES INC   |  ORAMETRIX INC   |  NEPHROGENEX, INC.   |  ANACOR PHARMACEUTICALS INC   |  TAPJOY, INC.   |  COULOMB TECHNOLOGIES, INC.   |  ANACOR PHARMACEUTICALS, INC.   |  NGM BIOPHARMACEUTICALS INC   |  JUST FABULOUS, INC.   |  CHARGEPOINT, INC.   |  GREENFLY, INC.   |  MMAX INVESTMENT PARTNERS, INC.
KIRK 
 
MAPLES 
EXECUTIVE OFFICER
ANACOR PHARMACEUTICALS INC   |  ANACOR PHARMACEUTICALS, INC.
RICHARD 
 
MARKHAM 
DIRECTOR
COLUCID PHARMACEUTICALS, INC.   |  VAXART, INC.   |  ANACOR PHARMACEUTICALS INC   |  NEPHROGENEX, INC.
GEOFFREY 
 
PARKER 
EXECUTIVE OFFICER
ANACOR PHARMACEUTICALS INC   |  ANACOR PHARMACEUTICALS, INC.   |  TRICIDA, INC.   |  BETTER THERAPEUTICS, INC.
DAVID 
 
PERRY 
EXECUTIVE OFFICER, DIRECTOR
AMNIS CORP   |  GAIKAI INC.   |  ANACOR PHARMACEUTICALS INC   |  ANACOR PHARMACEUTICALS, INC.   |  NUTRITION DEVELOPMENT GROUP, LLC   |  HYDRAULEX INTERNATIONAL HOLDINGS, INC.   |  FAREWELL LLC   |  UROTRONIC, INC.   |  CENTERCODE, INC.   |  GOVYRL, INC.   |  OPTILUME STRICTURE, LLC   |  BETTER THERAPEUTICS, INC.   |  HIGH RISE BEVERAGE COMPANY, LLC
JACOB 
 
PLATTNER 
EXECUTIVE OFFICER
ANACOR PHARMACEUTICALS INC   |  ANACOR PHARMACEUTICALS, INC.
WILLIAM 
 
RIEFLIN 
DIRECTOR
NGM BIOPHARMACEUTICALS INC   |  ANACOR PHARMACEUTICALS, INC.   |  FLEXUS BIOSCIENCES, INC.   |  KALLYOPE, INC.   |  LYCIA THERAPEUTICS, INC.
LUCY 
 
SHAPIRO 
DIRECTOR
ANACOR PHARMACEUTICALS INC   |  PACIFIC BIOSCIENCES OF CALIFORNIA, INC.   |  ANACOR PHARMACEUTICALS, INC.
LEE 
 
ZANE 
EXECUTIVE OFFICER
ANACOR PHARMACEUTICALS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2013-06-17
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2013-06-07 
2013-04-09
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2013-04-05 
2011-03-31
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
$25,000,001 - $100,000,000 
 
2011-03-18 
2010-12-03
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2010-11-30 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#